Cargando…

Oxygen-enhanced MRI MOLLI T1 mapping during chemoradiotherapy in anal squamous cell carcinoma

BACKGROUND AND PURPOSE: Oxygen-enhanced magnetic resonance imaging (MRI) and T1-mapping was used to explore its effectiveness as a prognostic imaging biomarker for chemoradiotherapy outcome in anal squamous cell carcinoma. MATERIALS AND METHODS: T2-weighted, T1 mapping, and oxygen-enhanced T1 maps w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bluemke, Emma, Bulte, Daniel, Bertrand, Ambre, George, Ben, Cooke, Rosie, Chu, Kwun-Ye, Durrant, Lisa, Goh, Vicky, Jacobs, Clare, Ng, Stasya M., Strauss, Victoria Y., Hawkins, Maria A., Muirhead, Rebecca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082428/ https://www.ncbi.nlm.nih.gov/pubmed/32211520 http://dx.doi.org/10.1016/j.ctro.2020.03.001

Ejemplares similares

Response of FDG avid pelvic bone marrow to concurrent chemoradiation for anal cancer
por: Robinson, Maxwell, et al.
Publicado: (2020)

Oxygen-enhanced MRI and radiotherapy in patients with oropharyngeal squamous cell carcinoma
por: Bluemke, Emma, et al.
Publicado: (2022)

Quantifying target-specific motion in anal cancer patients treated with intensity modulated radiotherapy (IMRT)
por: Durrant, Lisa, et al.
Publicado: (2016)

Modeling early haematologic adverse events in conformal and intensity-modulated pelvic radiotherapy in anal cancer
por: Robinson, Maxwell, et al.
Publicado: (2015)

Chemoradiotherapy in squamous cell carcinoma of the anal canal: a single institution experience
por: Kim, Kyung Hwan, et al.
Publicado: (2013)

The Role of Haematological Parameters in Predicting the Response To Radical Chemoradiotherapy in Patients with Anal Squamous Cell Cancer
por: Stojanovic-Rundic, Suzana, et al.
Publicado: (2021)

A song for Molly
por: Bernstein, Jeremy
Publicado: (2021)

Molly Fancher’s Bazaar
Publicado: (1890)

Are T1 values to characterize myocardial tissue equivalent between various sequences: comparison of MOLLI, shMOLLI, 3'5-MOLLI and SASHA
por: Puntmann, Valentina O, et al.
Publicado: (2013)

C-Reactive Protein-to-Albumin Ratio as Prognostic Marker for Anal Squamous Cell Carcinoma Treated With Chemoradiotherapy
por: Martin, Daniel, et al.
Publicado: (2019)

Phantom validation of 17 and 11 heartbeat MOLLI T1 mapping sequence at 3T
por: Liu, Songtao, et al.
Publicado: (2011)

Photobiomodulation as a treatment for dermatitis caused by chemoradiotherapy for squamous cell anal carcinoma: case report and literature review
por: Hottz, Fabiana, et al.
Publicado: (2022)

A Conversation with Molly Stevens
por: Brazil, Rachel
Publicado: (2021)

Reproducibility of native T1 mapping using ShMOLLI and MOLLI - implications for sample size calculation
por: Bhuva, Anish N, et al.
Publicado: (2016)

T1- and ECV-mapping in clinical routine at 3 T: differences between MOLLI, ShMOLLI and SASHA
por: Heidenreich, Julius F., et al.
Publicado: (2019)

Diffusion-weighted imaging complements T2-weighted MRI for tumour response assessment in squamous anal carcinoma
por: Prezzi, Davide, et al.
Publicado: (2023)

The impact of MRI sequence on tumour staging and gross tumour volume delineation in squamous cell carcinoma of the anal canal
por: Prezzi, Davide, et al.
Publicado: (2017)

Effective treatment of anal cancer in the elderly with low-dose chemoradiotherapy
por: Charnley, N, et al.
Publicado: (2005)

Combined PET-CT and MRI for response evaluation in patients with squamous cell anal carcinoma treated with curative-intent chemoradiotherapy
por: Adusumilli, Pratik, et al.
Publicado: (2022)

T1 values in discrimination between health and disease using different T1 sequences: comparison between 3'3'5-MOLLI, 3'5-MOLLI, shMOLLI and SASHA
por: Mahmoud, Islam Z, et al.
Publicado: (2014)

Improved T1 fitting with the MOLLI sequence
por: Cooper, Mitchell A, et al.
Publicado: (2013)

Cytotoxic Compounds from Brucea mollis
por: Tung, Mai Hung Thanh, et al.
Publicado: (2013)

Age-gender reference values of native myocardial T1 at 1.5T and 3T: comparison of MOLLI and shMOLLI
por: Dabir, Darius, et al.
Publicado: (2013)

Patterns and Predictors of Relapse Following Radical Chemoradiation Therapy Delivered Using Intensity Modulated Radiation Therapy With a Simultaneous Integrated Boost in Anal Squamous Cell Carcinoma
por: Shakir, Rebecca, et al.
Publicado: (2020)

Pre-contrast ShMOLLI T1 mapping in cardiac AL amyloidosis
por: Karamitsos, Theodoros, et al.
Publicado: (2012)

Anal Intraepithelial Neoplasia: Precursor of Anal Squamous Cell Carcinoma
por: Sakamoto, Taku, et al.
Publicado: (2022)

Multiparametric MRI as an outcome predictor for anal canal cancer managed with chemoradiotherapy
por: Jones, Michael, et al.
Publicado: (2015)

Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option
por: Meulendijks, D, et al.
Publicado: (2014)

Sarcopenia Is Associated With Hematologic Toxicity During Chemoradiotherapy in Patients With Anal Carcinoma
por: Martin, Daniel, et al.
Publicado: (2020)

IAP inhibitor plus chemoradiotherapy for the treatment of bulky anal canal carcinoma
por: De Felice, Francesca, et al.
Publicado: (2023)

Application of a high resolution T1 mapping with MOLLI (hrMOLLI) in patients in clinical setting: a reproducibility study
por: Pastor, Ana, et al.
Publicado: (2012)

Accuracy and precision of myocardial T(1)mapping with MOLLI and ShMOLLI at 1.5T and 3.0T: a phantom study
por: Falque, Claire, et al.
Publicado: (2014)

Accuracy and reproducibility of four T(1 )mapping sequences: a head-to-head comparison of MOLLI, ShMOLLI, SASHA, and SAPPHIRE
por: Roujol, Sébastien, et al.
Publicado: (2014)

Detection of Anal Intraepithelial Neoplasia and Anal Squamous Cell Carcinoma on Colonoscopy
por: Voss, Jordan K., et al.
Publicado: (2022)

Chemoradiotherapy with or without consolidation chemotherapy using cisplatin and 5-fluorouracil in anal squamous cell carcinoma: long-term results in 31 patients
por: Cho, Byoung Chul, et al.
Publicado: (2008)

Comparison of MOLLI and ShMOLLI at 1.5 and 3 Tesla for detection of early cardiac iron deposition in patients with transfusional siderosis
por: Cheng, Andrew L, et al.
Publicado: (2016)

FDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy
por: Day, F L, et al.
Publicado: (2011)

Systematic review of outcome measures following chemoradiotherapy for the treatment of anal cancer (CORMAC)
por: Fish, R., et al.
Publicado: (2018)

Biomarkers in anal cancer: from biological understanding to stratified treatment
por: Jones, Christopher M, et al.
Publicado: (2017)

Research on Anal Squamous Cell Carcinoma
por: Jethwa, Krishan R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ci5akvq5bhibtkroglmgtrcihd